logo-loader

Directa Plus secures key patent in the US for its manufacturing process

Published: 06:24 01 Jul 2019 EDT

Giulio Cesareo, chief executive of graphene specialist Directa Plus PLC (LON:DCTA), tells Proactive London's Andrew Scott they've been awarded a patent in the US for its manufacturing process that just uses water with no chemicals or solvents.

He says this sustainability's already proving attractive to US companies.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

48 minutes ago